COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 58: Articles 571-580  | Next

One Thousand SARS-CoV-2 Antibody Structures Reveal Convergent Binding and Near-Universal Immune Escape
Feng, Z., Sang, Z., Xiang, Y., Escalera, A., Weshler, A., Schneidman- Duhovny, D., Garcia-Sastre, A., Shi, Y.
10.1101/2025.08.07.669152 — Posted: 2025-08-08
A new method to measure Baroreflex sensitivity impairment in Long Covid patients with Hyperadrenergic POTS-like symptoms
Sainz-Jimenez, A., Romero Fragoso, I., Salazar Calderon, G. E., Martinez Falcon, S., Luna, H. M., Portocarrero Nieto, J., Gonzalez, F. d. J., Reyes Cruz, T., Becerra-Luna, B., Martinez-Memije, R., Chiquete, E., Tamez-Torres, K. M., Sifuentes-Osornio, J., Fossion, R., Estanol, B., Aceves Buendia, J. d. J.
10.1101/2025.08.05.25332555 — Posted: 2025-08-07
Detection of Long COVID Microclots using Pulsed Speckle Contrast Optical Spectroscopy
Rasouli, R., Hartl, B., Konecky, S. D.
10.1101/2025.08.06.669007 — Posted: 2025-08-07
Ultra-parallel ribosome profiling platform with RNA-dependent RNA amplification
Shichino, Y., Mito, M., Kinugasa, Y., Wakigawa, T., Yamashita, A., Mishima, Y., Imai, Y., Iwasaki, S.
10.1101/2025.08.06.668979 — Posted: 2025-08-07
Factors that influenced testing positive and dying from COVID-19 in the West South-Central Division of the United States and its Effects on Future Public Health Policy
Kaliba, A. R.
10.1101/2025.08.01.25332736 — Posted: 2025-08-06
In Vivo Evolution of Monoclonal Antibody CR3022 to Achieve Cross-Neutralization of SARS-CoV-2 and Implications for Vaccine Strategies Against SARS-Related Viruses
Fu, Y., Feng, Z., Erickson, S. A., Halfmann, P. J., Li, L., Chervin, J. C., Troxell, C. A., Sun, J., Yasuhara, A., Changrob, S., Huang, M., Zheng, N.-Y., Yuan, M., Kawaoka, Y., Wilson, I. A., Wilson, P.
10.1101/2025.08.05.666673 — Posted: 2025-08-06
Escape from SARS-CoV-2 Nsp1-mediated host shutoff by TIAR transcript reveals general features of Nsp1 resistance
Galbraith, C., Stolz, M., Tersteeg, S., Andrews, E., Patel, T. R., Khaperskyy, D. A.
10.1101/2025.08.04.668557 — Posted: 2025-08-06
When the unexpected pandemic began, what were the experiences of healthcare professionals in the management of COVID-19 in Lesotho?
Nyangu, I., Ramathebane, M.
10.1101/2025.08.01.25332516 — Posted: 2025-08-05
Revealing associations between exposure to cyanobacteria toxins and COVID-19 outcomes in Colorado
Thessen, A. E., ONeil, S. T., Haendel, M. A., National Clinical Cohort Collaborative (N3C) COVID Enclave
10.1101/2025.08.01.25332749 — Posted: 2025-08-05
Network-based proactive contact tracing: A pre-emptive, degree-based alerting framework for privacy-preserving COVID-19 apps
Diallo, D., Hecking, T.
10.1101/2025.08.01.25332740 — Posted: 2025-08-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).